Heterologous integration-assisted metabolic engineering in Escherichia coli for elevated D-pantothenic acid production
- PMID: 40803582
- DOI: 10.1016/j.ymben.2025.08.003
Heterologous integration-assisted metabolic engineering in Escherichia coli for elevated D-pantothenic acid production
Abstract
D-pantothenic acid (D-PA) is a vital water-soluble vitamin with diverse industrial applications, driving the demand for efficient microbial production. Here, we rationally engineered an Escherichia coli strain to enhance D-PA production through metabolic engineering. First, to enhance carbon utilization efficiency, competing byproduct pathways were deleted and the pentose phosphate pathway was downregulated. Next, the glucose and β-alanine transport systems were strategically enhanced, and cofactor availability was improved through engineering NADPH regeneration and ATP recycling pathways. Subsequently, pathway engineering was applied to fine-tune the expression of heterologous enzymes, thereby enhancing the metabolic pull toward D-PA biosynthesis. To enhance the supply of one-carbon donor required by the rate-limiting enzyme ketopantoate hydroxymethyltransferase (KPHMT), a heterologous 5,10-methylenetetrahydrofolate biosynthesis module was introduced. Finally, dynamic regulation of isocitrate synthase and pantothenate kinase was implemented to balance cell growth and D-PA production. As a result of the integrated metabolic engineering strategies, the final strain DPZ28/P31 achieved a D-PA titer of 98.6 g/L and a yield of 0.44 g/g glucose in a two-stage fed-batch fermentation. These findings provide valuable insights for industrial-scale production of D-PA and related compounds.
Keywords: Cofactor regeneration; D-pantothenic acid; Dynamic regulation; Escherichia coli; One-carbon donor; Substrate transport.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Metabolic engineering of Escherichia coli for high-yield dopamine production via optimized fermentation strategies.Appl Environ Microbiol. 2025 Jun 18;91(6):e0015925. doi: 10.1128/aem.00159-25. Epub 2025 May 8. Appl Environ Microbiol. 2025. PMID: 40338089 Free PMC article.
-
Synergistic Production of Lycopene and β-Alanine Through Engineered Redox Balancing in Escherichia coli.Int J Mol Sci. 2025 Jul 14;26(14):6727. doi: 10.3390/ijms26146727. Int J Mol Sci. 2025. PMID: 40724976 Free PMC article.
-
Tailoring Escherichia coli for high-yield production of O-acetyl-L-homoserine through multi-node metabolic regulation.Metab Eng. 2025 Sep;91:455-465. doi: 10.1016/j.ymben.2025.06.010. Epub 2025 Jun 30. Metab Eng. 2025. PMID: 40602483
-
A Comprehensive Review of l-Theanine Production in Escherichia coli: The Recent Progress, Metabolic Engineering Strategies, and Future Prospects.ACS Synth Biol. 2025 Jul 18;14(7):2433-2444. doi: 10.1021/acssynbio.5c00291. Epub 2025 Jul 4. ACS Synth Biol. 2025. PMID: 40613122 Review.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
LinkOut - more resources
Full Text Sources
Research Materials